The book is a wake-up call to Jewish women over 40.
I myself can’t always fully embrace faith, and the God I believe in is not one who controls the onset or delay of disease or sudden disaster. And yet, I want to advocate for tefillah, the power of prayer.
Women with the BRCA1 mutation can reduce their risk of cancer by removing their ovaries. But Tamar Fox writes the media should stop telling women what to do with their bodies.
Testing for BRCA genetic mutations, tied to breast and ovarian cancers in Jewish women, isn’t common, despite proven risks. Marcia Watson-Levy learned the danger firsthand.
Regulatory hurdles plague a new class of cancer drugs that showed encouraging results. Those obstacles have frustrated carriers of cancer-causing mutations, for whom medicine might prove helpful.
The genetic mutations that greatly increase a woman’s chance of getting breast cancer — mutations that are common among Ashkenazi Jewish women — also put her at high risk for ovarian cancer. So it makes sense that Sharsheret, which, since 2001, has been offering free support services to young Jewish women living with (or at high risk for) breast cancer, will be expanding to provide for women with ovarian cancer and those predisposed to the disease.